Search Results - "Zakeri, K."

‘Optimism bias’ in contemporary national clinical trial network phase III trials: are we improving? by Zakeri, Kaveh, Noticewala, Sonal, Vitzthum, Lucas, Sojourner, E., Shen, Hanjie, Mell, Loren

“…Previous studies have found that overestimating treatment effects (i.e. ‘optimism bias’) leads to underpowered clinical trials. The prevalence of ‘optimism…”
Get full text

Long-term Risks of Radiation Therapy for Stage II/III Rectal Cancer by Zakeri, K, Hwang, L, Murphy, J.D

Get full text

Competing Event Models Reduce Clinical Trial Costs in Elderly Cancer Patients by Zakeri, K, Carmona, R, Green, G, Murphy, J.D, Mell, L.K

Get full text

Competing Event Models Improve Risk Stratification of Elderly Breast Cancer Patients by Carmona, R, Hwang, L, Green, G, Zakeri, K, Murphy, J.D, Mell, L.K

Get full text

Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC) by Zakeri, K., Rotolo, F., Lacas, B., Vitzthum, L.K., Le, Q.-T.X., Gregoire, V., Overgaard, J., Tobias, J., Zackrisson, B., Parmar, M.K., Burtness, B.A., Ghi, M.G., Sanguineti, G., O'Sullivan, B., Fortpied, C., Bourhis, J., Shen, H., Harris, J., Pignon, J.-P., Mell, L.K.

Get full text

Comparison of Acute and Late GI and GU Toxicity Following Whole-pelvis Versus Prostate-only IMRT With Daily Image Guidance by Lu, S.M, Zakeri, K, Einck, J.P, Sandhu, A.P

Get full text

Improving the Efficiency of Clinical Trials Through Selection Models by Zakeri, K, Rose, B.S, Mell, L.K

Get full text

Population-Based Study of Comorbidity and Noncancer Mortality in Head-and-Neck Cancer by Gulaya, S, Carmona, R, Zakeri, K, Vaida, F, Mell, L

Get full text

Single Isocenter Frameless Volumetric Modulated Arc Radiosurgery for Multiple Intracranial Metastases by Zhao, X, Lau, S.K.M, Zakeri, K, Carmona, R, Knipprath, E, Simpson, D.R, Nath, S.K, Kim, G.Y, Sanghvi, P, Hattangadi, J.A, Chen, C, Murphy, K.T

Get full text

Longitudinal Study of Acute Hematologic Function in Cervical Cancer Patients Treated With Chemoradiation Therapy by Zhu, H, Dadachanji, K.K, Zakeri, K, Hasan, Y, Yashar, C, Mell, L

Get full text

CT and MRI-based Image Guided Brachytherapy for Cervical Cancer: A Multi-institutional Report by Simpson, D, Yashar, C.M, Kannan, N, Zakeri, K, McMurtrie, R, Einck, J, Mell, L, Kim, H, Scanderbeg, D, Beriwal, S

Get full text

Temperature-driven change of morphology and magnetic anisotropy of Fe monolayers on GaAs(001) by Zakeri, K., Urban, C., Kebe, T., Lindner, J., Köhler, U., Farle, M.

“…The thickness- and temperature-dependent irreversible change of morphology and magnetic parameters of 5 and 10 monolayers (ML) of Fe on GaAs(001) are…”
Get full text

Nomogram to Predict Risk of Early Mortality Following Definitive or Adjuvant Radiation and Systemic Therapy for Head and Neck Cancer by Raab, G.T., Yu, Y., Sherman, E., Wong, R.J., Mell, L.K., Lee, N.Y., Zakeri, K.

“…Tools to predict individual patient risk for early mortality in head and neck cancer patients receiving chemoradiation are lacking. We sought to create a…”
Get full text

Impact of Surveillance Imaging in Patients with HPV-Associated Oropharyngeal Carcinomas Treated with Definitive Radiation and Chemotherapy by Shang, T., Raab, G., Chen, L., Yu, Y., Shamseddine, A., Riaz, N., McBride, S.M., Gelblum, D., Lee, N.Y., Zakeri, K.

“…Post-treatment surveillance imaging for HPV-associated oropharyngeal carcinomas (OPCs) differs among physicians and institutions. Surveillance imaging can…”
Get full text

Outcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers by Zakeri, K., Shang, T., Yu, Y., Chen, L., Shamseddine, A., Kang, J.J., Tsai, C.J., Sherman, E., Wong, R.J., McBride, S., Gelblum, D., Riaz, N., Lee, N.Y.

“…Reducing elective nodal irradiation dose can decrease treatment toxicity and improve quality of life for head and neck cancer patients. The elective…”
Get full text

Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis by Miller, D.G., Youssef, I., Kallini, D., Yu, Y., Zakeri, K., Chen, L., Shamseddine, A., Gelblum, D., McBride, S., Riaz, N., Aliotta, E., Aristophanous, M., Lee, N.Y.

“…Our standard treatment for HPV+ OPC is 30Gy to the subclinical region followed by a 40Gy cone down to the gross tumor. With this approach, we have not observed…”
Get full text

Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology by Hesse, J., Zakeri, K., Chen, L., Yu, Y., Kang, J.J., Riaz, N., Tsai, C.J., McBride, S., Gelblum, D., Lee, N.Y.

Get full text

Triggered GTV-Based Offline Adaptation for LINAC Head and Neck Radiotherapy by Aristophanous, M., Aliotta, E., Cervino, L.I., Caringi, A., Lichtenwalner, P., Zhang, P., Zakeri, K., Tsai, C.J., Hu, Y.C., Lee, N.Y.

Get full text

Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imaging by Zakeri, K., Gelblum, D., Chen, L., Kriplani, A., Wong, W., Zhang, Z., Lopez, A., Wong, R.J., Cracchiolo, J.R., Sherman, E., Lee, N.Y.

“…The incidence of Human Papilloma Virus (HPV) associated oropharyngeal cancer has risen rapidly over the past two decades with excellent prognosis and high…”
Get full text

Pilot Randomized Clinical Trial of Geriatric Comanagement or Geriatric Guided Supportive Care for Older Patients with Head and Neck CancerReceiving Radiation and Chemotherapy by Zakeri, K., Gelblum, D., Shahrokni, A., Zhang, Z., Lopez, A., Kim, S.J., Alexander, K., Amirnia, F., Sun, S.W., Korc-Grodzicki, B., Lee, N.Y.

“…The standard of care for locally advanced head and neck cancer (HNC) includes radiation with concurrent chemotherapy due to superior disease control. Older…”
Get full text